RIÑÓN Y ENFERMEDAD CARDIOVASCULAR - Seden

BIBLIOGRAFÍA
1438. Kohse KP, Feifel K, Mayer-Wehrstein R. Differential regulation
of brain and atrial natriuretic peptides in hemodialysis
patients. Clin Nephrol 40:83-90, 1993.
1439. Fishbane S, Natke E, Maesaka JK. Role of volume overload
in dialysis-refractory hypertension. Am J Kidney Dis 28:257,
1996.
1440. Zoccali C, Mallamaci F, Benedetto FA, Tripepi G, Parlongo S,
Cataliotti A, y cols. Cardiac natriuretic peptides are related
to left ventricular mass and function and predict mortality in
dialysis patients. J Am Soc Nephrol 12:1508-1515, 2001.
1441. Charra B, Bergstrom J, Scribner BH. Blood pressure control
in dialysis patients: importance of the lag phenomenon. Am
J Kidney Dis 32: 720-724, 1988.
1442. Khosla UM and Johnson RJ. Hypertension in the hemodialysis
patient and the “Lag Phenomenon”: Insights into
pathophysiology and clinical management. Am J Kidney Dis
43:739-751, 2004.
1443. Freis ED, Reda DJ, Materson BJ. Volume (weight loss) and
blood pressure response following thiazide diuretics.
Hypertension 12:244, 1988.
1444. Charra B, Laurent G, Calemard E. Survival in dialysis and
blood pressure control. Contrib Nephrol 106: 179-185,
1994.
1445. 1444. 1658. Luik AJ, van der Sande FM, Weideman P,
Cheriex E, Kooman JP, Leunissen KM. The influence of increasing
dialysis treatment time reducing dry weight on
blood pressure control in haemodialysis patients: a prospective
study. Am J Nephrol 21: 471-478, 2001.
1446. Charra B, Calemard E, Laurent G. Importance of treatment
time and blood pressure control in achieving long-term survival
on dialysis. Am J Nephrol 16:35-44, 1996.
1447. Krautzig S, Janssen U, Koch KM, Granolleras C, Shaldon S.
Dietary salt restriction and reduction of dialysate sodium to
control hypertension in maintenance haemodialysis
patients. Nephrol Dial Transplant 13:552-553, 1998.(letter)
1448. Sang GL, Kovithavongs C, Ulan R, Kjellstrand CM. Sodium
ramping in hemodialysis: A study of beneficial and adverse
effects. Am J Kidney Dis 29:669-677, 1997.
1449. Flanigan MJ, Khairullah QT, Lim VS. Dialysate sodium delivery
can alter chronic blood pressure management. Am J
Kidney Dis 29:383-391, 1997.
1450. Chazot C, Charra B, Laurent G, Didier C, Vo Van C, Terrat JC
y cols. Interdialysis blood pressure control by long haemodialysis
sessions. Nephrol Dial Transplant 10:831-837, 1995
1451. McGregor DO, Buttimore AL, Nicholls MG, Lynn KL.
Ambulatory blood pressure monitoring on patients receiving
long, slow home haemodialysis. Nephrol Dial Transplant
14:2676-2679, 1999.
1452. Zoccali C, Bode-Boger S, Mallamaci F, Benedetto F, Tripepi
G, Malatino L, y cols. Plasma concentration of asymmetrical
dimethylarginine and mortality in patients with end-stage
renal disease: a prospective study. Lancet 358:2113-7,
2001.
1453. Katzarski KS, Charra B, Luik AJ, Nisell J, Divino Filho JC,
Leypoldt JK y cols. Fluid state and blood pressure control in
patients treated with long and short haemodialysis. Nephrol
Dial Transplant 14:369-375, 1999.
1454. Pierratos A, Ouwendyk M, Francoeur R, Vas S, Raj DS,
Ecclestone AM y cols. Nocturnal hemodialysis: Three-year
experience. J Am Soc Nephrol 1998; 9:859-868, 1998.
1455. Hanly P, Pierratos A. Improvement of sleep apnea in patients
with chronic renal failure who undergo nocturnal hemodialysis.
N Engl J Med 344:102-107, 2001.
1456. Pierratos A. Nocturnal home haemodialysis. An update on a
5-year experience. Nephrol Dial Transplant 14:2835-2840,
1999.
1457. Buoncristiani U, Quintaliani G, Cozzari M, Giombini L,
Ragaiolo M. Daily dialysis. Long-term clinical metabolic
results. Kidney Int (suppl 24): 33:S137-S140, 1998.
1458. Pinciaroli AR. Results of daily haemodiaylsis in Catanzaro.
12-year experience with 22 patients treated for more than
one year. Home Hemodial Int 2:12-17, 1998
1459. Luik AJ, Charra B, Katzarski K, Habets J, Cheriex EC,
Menheere PP y cols. Blood pressure control and hemodynamic
changes in patients on long time dialysis treatment.
Blood Purif 16:197-209, 1998.
1460. Locatelli F, Covic A, Chazot C, Leunissen K, Luño J, Yaqoob
M. Hypertension and cardiovascular risk assessment in
dialysis patients. Nephrol Dial Transplant 19:1058-1068,
2004.
1461. Zazgornik J, Biesenbach F, Forstenlehner M, Stummvoll K.
Profile of antihypertensive drugs in hypertensive patients on
renal replacement therapy (RRT). Clin Nephrol 48:337-440,
1997.
1462. Fishbane SA, Scribner BH. Blood pressure control in dialysis
patients. Semin Dial 15:144-145, 2002.
1463. Morse SA, Dang AN, Thakur V, Zhang R, Reisin E.
Hypertension in chronic dialysis patients pathophysiology,
monitoring, and treatment. Am J Med Sci 325: 194-201,
2003.
1464. Griffith TF, Chua BSY, Allen AS, Klassen PS, Donal NR,
Szczech LA. Characteristics of treated hypertension in incident
hemodialysis and peritoneal dialysis patients. Am J
Kidney Dis 42:1260-1269, 2003.
1465. Kestenbaum B, Gillen DL, Sherrard DJ, Seliger S, Ball A,
Stehman-Breen C . Calcium chanel blocker use and mortality
among patients with end-stage renal disease. Kidney Int
61:2157, 2002.
1466. Yusuf S, Sleight P, Pogue J, Bosch J, Davies R, Dagenais G.
Effects of an angiotensin-converting-enzyme inhibitor, ramipril,
on cardiovascular events in high-risk patients. The Heart
Outcomes Prevention Evaluation Study Investigators. N Engl
J Med 342: 145-53, 2000.
1467. Sica DA. Pharmacotherapy in congestive heart failure:
angiotensin II and thirst: therapeutic considerations. Congest
Heart Fail 7(6):325-328, 2001.
1468. Dhondt AW, Vanholder RC, Ringoir SM. Angiotensin-converting
enzyme inhibitors and higher erythropoietin requirement
in chronic hemodialysis patients. Nephrol Dial
Transplant 10:2107, 1995.
1469. Toto R, Shultz P, Raij L, Mitchell H, Shaw W, Ramjit D y cols.
Efficacy and tolerability of losartan in hypertensive patients
with renal impairment. Collaborative Group. Hypertension
31: 684-91, 1998.
1470. Saracho R, Martin-Malo A, Martinez I, Aljama P, Montenegro
J. Evaluation of the Losartan in Haemodialysis (ELHE) Study.
Kidney Int 68 (Suppl 1): S125-9, 1998.
1471. Foley RN, Herzog CA, Collins AJ. Blood pressure and longterm
mortality in United States hemodialysis patients:
USRDS Waves 3 and 4 Study. Kidney Int 62: 1784-1790,
2002.
231